The unprecedented challenges of the COVID-19 pandemic spurred many organizations to initiate new projects, tailored to address the newly emerged needs and obstacles. One such organization is the biotechnology company Moderna, which undertook the project of developing an mRNA-based vaccine. The project initiation force was primarily the global demand for a medical solution to halt the spread of the virus, combined with the urgency imposed by the pandemic's escalation. The organization's goal was to achieve rapid development and distribution of an effective vaccine to combat COVID-19